Northwest Biotherapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	305	352	744	777	583	1,026
Market Cap Growth	-3.80%	-52.72%	-4.28%	33.17%	-43.13%	790.70%
Enterprise Value	379	420	797	809	603	1,038
Last Close Price	0.18	0.31	0.65	0.78	0.58	1.27
PE Ratio	-	-	-	-	3.70	-
PS Ratio	381.85	263.35	425.38	493.23	660.04	971.84
PB Ratio	-3.76	-4.61	-17.47	-7.90	-5.35	-3.46
EV/Sales Ratio	-	314.92	455.93	513.96	682.10	983.37
Debt / Equity Ratio	-0.81	-0.85	-0.97	-0.25	-0.31	-0.05
Net Debt / Equity Ratio	-0.76	-0.83	-0.92	-0.18	-0.18	-0.03
Net Debt / EBITDA Ratio	-1.15	-1.01	-0.80	-0.29	-0.43	-0.11
Net Debt / FCF Ratio	-1.42	-1.12	-0.76	-0.35	-0.51	-0.25
Asset Turnover	0.03	0.05	0.07	0.05	0.03	0.06
Quick Ratio	0.05	0.03	0.05	0.06	0.11	0.03
Current Ratio	0.08	0.06	0.09	0.08	0.13	0.04
Return on Assets (ROA)	-135.38%	-152.28%	-117.23%	-117.48%	-90.17%	-248.63%
Return on Capital Employed (ROCE)	113.30%	160.10%	320.10%	71.00%	56.30%	24.80%
Earnings Yield	-25.50%	-23.02%	-7.62%	-12.65%	27.00%	-42.23%
FCF Yield	-14.21%	-15.95%	-6.94%	-6.71%	-6.68%	-3.08%
Buyback Yield / Dilution	-16.16%	-10.99%	-10.17%	-0.79%	-38.99%	-28.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.